Solid Biosciences Inc.
SLDB
Positions held
Your positionsSLDB isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $731.28M | Enterprise value | $373.75M | Trailing P/E | — | Forward P/E | -4.00 |
| PEG | — | Price / book | 1.92 | Beta | 2.47 | Dividend yield | 0.00% |
| Revenue growth | — | Earnings growth | — | Gross margin | 0.0% | Operating margin | 0.0% |
| Profit margin | 0.0% | ROE | -65.5% | ROA | -36.4% | Debt / equity | 0.05 |
| Current ratio | 13.82 | Free cash flow | -$118.24M | Analyst recommendation | strong_buy | Mean target | $18.62 |
| 52w high | $11.45 | 52w low | $3.79 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | — |
| Op margin | — | — | — | — | — | — |
| Net income | -$54.8M | -$56.7M | -$49.8M | -$45.8M | -$39.5M | — |
| Gross margin | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$57.4M | -$57.3M | -$49.4M | -$48.1M | -$41.7M | — |
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $8.1M | — |
| Op margin | — | — | — | -1226.5% | — |
| Net income | -$174M | -$125M | -$96.0M | -$86.0M | — |
| Gross margin | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | -$179M | -$130M | -$104M | -$99.3M | — |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-01 · Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-09-16 · Solid Biosciences' Duchenne Muscular Dystrophy Approach, FDA Shift Support Upside, RBC Says
2026-09-16 · RBC Initiates Solid Biosciences at Outperform, Speculative Risk With $18 Price Target
2026-09-02 · Solid Biosciences to Participate at Upcoming Investor Conferences
2026-08-07 · Wedbush Adjusts PT on Solid Biosciences to $15 From $16, Maintains Outperform Rating
2026-08-06 · Solid Biosciences Reports Second Quarter 2026 Financial Results and Provides Business Updates
Price (daily)
Full chart · RSI · MACD · patterns